NCT05001282
Breast Cancer Type: Triple Negative
Hormone Mutations:
Other Mutations:
Breast Cancer Tissue:
Recruitment Status: Recruiting
Phase 1|Phase 2
Drug Category: Misc Inhibitor
Key Eligibility Criteria:
Gender: All
Age: 18 Years and older (Adult, Older Adult)
Location of Metastases:
Additional Notes:
Exclusions: Patient with active symptomatic central nervous system (CNS) metastases that is larger than 3 cm or requires treatment – see trial for details
https://ClinicalTrials.gov/show/NCT05001282